<!DOCTYPE html>
<html lang="en">
<head>
  <meta charset="UTF-8">
  <meta name="viewport" content="width=device-width, initial-scale=1.0">
  <title>The London Longevity Newsletter â€” Issue 11 - Hex Index</title>
  <link rel="stylesheet" href="../../styles.css">
</head>
<body class="reading-mode">
  <header class="reading-header">
    <a href="../../index.html" class="back-link">&larr; Back to Library</a>
  </header>
  <main class="reading-content">
    
    <article class="article-page">
      <header class="article-header">
        <h1>The London Longevity Newsletter â€” Issue 11</h1>
        <div class="article-meta">
          <span class="author">By Various</span>
          <span class="separator">&middot;</span>
          <a href="../../publication/londonlongevity/index.html" class="publication">
            London Longevity Newsletter
          </a>
          <span class="separator">&middot;</span><time>Oct 10, 2025</time>
          <span class="separator">&middot;</span>
          <span class="read-time">6 min read</span>
        </div>
      </header>

      

      <div class="article-excerpt">
        <p>Welcome to Issue 11 of the London Longevity Newsletter <strong>ğŸ—ï¸</strong></p><p><strong>âš¡Upcoming London Longevity Network event, in collaboration with Longevity Hacks </strong></p><p><strong>Women X Longevity: London Hackathon, 17-19th October</strong></p><p>We are excited to host the <strong>first-ever hackathon</strong> dedicated to<strong> womenâ€™s longevity</strong>.</p><p>No matter your background - <strong>engineers, scientists, clinicians, founders</strong> - this is your chance to tackle the biggest unmet needs in female lifespan and reproductive longevity.<strong> </strong>It is also <strong>open to all genders; womenâ€™s health is not only a womenâ€™s problem to solve.</strong><br><br><strong>You can join:</strong></p><ul><li><p>â€‹<strong>Panel only:</strong> 17 October</p></li><li><p>â€‹<strong>Panel + Hackathon:</strong> 17â€“19 October</p></li></ul><p>â€‹<strong>Expect:</strong></p><ul><li><p>â€‹Panel on women health opportunities + Network</p></li><li><p>â€‹World-class mentors and domain experts</p></li><li><p>â€‹Access to credits, datasets, and AI tools</p></li><li><p>â€‹Workshops on AI tools and models from Hugging Face, Manus, Biomni and Netmind</p></li><li><p>â€‹Prizes and post hack support</p></li></ul><p>Sign up here: <a href="https://luma.com/wkht62b5">https://luma.com/wkht62b5</a> </p><p>ğŸš¨ Prior to the Panel and Hackathon, we have <strong>four </strong>additional <strong>Virtual Workshops</strong>, running between <strong>10th to 16th</strong> <strong>October:</strong> </p><ul><li><p>Build and Deploy AI with <a href="https://luma.com/c3qvo4ca">NetMind</a>, 10 Oct</p></li><li><p>Hands on AI with <a href="https://luma.com/8hqrnd7e">Manus AI</a>, 13 Oct</p></li><li><p>ML for Scientific Research with <a href="https://luma.com/pd5cu3r0">Hugging Face</a>, 14 Oct</p></li><li><p>Building with <a href="https://luma.com/3q5lbd2n">Biomni</a>, 16 Oct</p></li></ul><p>(The Workshops are especially valuable for those participating in the Hackathon, but anyone else is welcome to join!)  </p><p>Letâ€™s dive in! ğŸ§ª</p><h2><strong>RESEARCH SPOTLIGHT</strong> ğŸ§¬</h2><ul><li><p><strong>Huntingtonâ€™s disease treated for first time using gene therapy</strong><br>A landmark early trial shows that a single dose of a gene therapy can slow Huntingtonâ€™s disease progression by up to 75% over three years, marking the first treatment to alter the course of this fatal neurodegenerative disorder. Developed by uniQure, the therapy delivers a viral vector carrying microRNA into the striatum, where it silences the mutant <em>huntingtin </em>gene and lowers toxic protein levels. Participants tolerated the procedure well, though the required brain surgery remains invasive. The promising results, if replicated, could usher in a new era for gene-based neurology, where permanent molecular â€œmuzzlesâ€ replace lifelong symptom management, but questions of durability, safety, and access linger as costs are expected to exceed $1 million per patient currently. <strong><a href="https://www.nature.com/articles/d41586-025-03139-9">Read More</a></strong></p></li><li><p><strong>Can ageing clocks guide cancer immunotherapy?</strong><br>A new review connects cellular senescence, the stress-induced, permanent cell-cycle arrest that shapes both tumour suppression and progression, with the rise of ageing clocks that quantify biological rather than chronological age. The authors trace how senescent cells, through the p53/p21 and p16/Rb axes and their pro-inflammatory secretome </p></li>...</ul>
      </div>

      <div class="read-full-article">
        <a href="https://londonlongevity.substack.com/p/the-london-longevity-newsletter-issue-651" class="read-button" target="_blank" rel="noopener">
          Read full article on London Longevity Newsletter &rarr;
        </a>
        <p class="copyright-note">
          This excerpt is provided for preview purposes.
          Full article content is available on the original publication.
        </p>
      </div>
    </article>
  
  </main>
</body>
</html>